Hims Hers Health is trading 11.9% down at $25.84 as investors extend a recent bout of profit-taking following a sharp rally earlier in July.
- The stock's decline occurs despite strength in the broader healthcare sector, appearing tied to the continued unwinding of recent gains.
- A weaker overall market and elevated geopolitical tensions are weighing on risk appetite, further pressuring the share price.